Showing results (431-440 of 558) with videos related to

Sort By:
Pageof 56
International Journal of Cancer|October 14, 2021
A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISEHeather Payne, Angus Robinson, Bernard Rappe, et al.
Clinical and Experimental Rheumatology|October 13, 2022
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohortElisa Gremese, Francesco Ciccia, Carlo Selmi, et al.
Arthritis Research & Therapy|October 11, 2023
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter studyMichele Maria Luchetti Gentiloni, Valentino Paci, Antonio Carletto, et al.
European Urology Focus|May 22, 2025
Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life-A Systematic Review and Meta-analysisTamás Fazekas, Marcin Miszczyk, Alexander Giesen, et al.
Rheumatology (Oxford, England)|April 5, 2026
Real-world application of the international myositis assessment and clinical studies group guidelines on cancer risk stratificationMaria Rosa Pellico, Cristina Bochicchio, Claudia Iannone, et al.
Rheumatology (Oxford, England)|March 26, 2021
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) databaseAntonietta Gigante, Anna-Maria Hoffmann-Vold, Danilo Alunni Fegatelli, et al.
The Journal of Experimental Medicine|March 2, 2016
Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defectsRosita Rigoni, Elena Fontana, Simone Guglielmetti, et al.
Rheumatology (Oxford, England)|September 13, 2022
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR databaseMichele Iudici, Denis Mongin, Elise Siegert, et al.
The Oncologist|July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomyRenate Pichler, Josef Fritz, Andrea Mari, et al.
Annals of the Rheumatic Diseases|March 18, 2026
Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST scoreAnn-Christin Pecher, Marouane Boubaya, Yannick Allanore, et al.
Pageof 56